RNA Delivery Function for Anticancer Therapeutics
RNA Delivery Function for Anticancer Therapeutics
Madkour, Loutfy H.
Taylor & Francis Ltd
01/2022
404
Dura
Inglês
9781032135168
15 a 20 dias
1383
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in cancer treatment nano-biotechnology
Cancer epigenetic mechanisms-DNA methylomes, histone codes and miRNAs
Chapter 02
Circulating miRNAs cancer biomarkers and epigenetic modifications in human cancer
Chapter 03
The role of circulating microRNAs in diagnosis, prognosis and treatment targets of cancer and diseases
Chapter 04
MicroRNAs potential in human cancer as therapeutic targets and novel biomarkers
Chapter 05
Biological function of miRNAs and piRNAs targets in cancer tissues
Chapter 06
Delivery strategies for siRNA and modifications process of RNAi therapeutics for cancer treatment
Chapter 07
Clinical small interfering siRNA-based conjugate systems for RNAi cancer cells therapy
Chapter 08
Potential targeted for siRNA in types of genetic diseases cancer therapeutics
Chapter 09
Recent advanced of microRNA molecules delivery as anticancer drugs
Chapter 10
DNA damaging cancer therapies and FDA novel drug approvals
Chapter 11
Therapeutic potential role of miRNAs in pancreatic and prostate cancer cells
Chapter 12
Regulation of microRNAs and their role in regeneration and cancer diseases
Chapter 13
Novel classes of non-coding RNAs (ncRNAs) and cancer biology therapeutic targets
Chapter 14
Advances in the inhibition and optimization of checkpoint kinases by small molecules for the treatment of cancer
Chapter 15
Recent therapeutic prospects of microRNAs and siRNA delivery systems in cancer treatment nano-biotechnology